ObesityT2Dknee osteoarthritisend-stage kidney disease
…ction may be indicated to achieve greater therapeutic benefit B.Obesity is a heterogeneous disease with varying effects on health, nece…
14articles mentioning diseases
32disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: steatohepatitis ×
steatohepatitis
This disease is selected. Its supporting articles are shown below.
Articles mentioning steatohepatitis
14 articles · page 1 of 2steatohepatitisMASLDtype 2 diabetes mellitusmetabolic syndrome
…atohepatitisAlteration of demographic & metabolic parameters in steatohepatitis subjects with or without T2DParameters (normal value)T2D (N=40)…
steatohepatitisliver fibrosisMASHsemaglutide
…ibrosis, and improvement in liver fibrosis with no worsening of steatohepatitis.A secondary analysis of part 1 evaluated treatment response thr…
hepatocellular carcinomaSAHsteatohepatitisalcohol-related cirrhosisAFDliver transplantation
…dergone liver transplantation for alcohol-related cirrhosis and hepatocellular carcinoma 2 years and 3 months before presentation. AFD cases were histol…
steatohepatitisMASLDtype 2 diabetes mellitus (T2DM)metabolic dysfunction-associated steatotic liver disease (MASLD)tirzepatideZepboundMounjarosemaglutideWegovyOzempic
…onist. Phase II data show tirzepatide is effective in resolving steatohepatitis in patients with MASLD with fibrosis at 52 weeks.2 However, no …
non-alcoholic fatty liver diseaseliver failuresteatohepatitisGLP-1 receptor agonistsvitamin E
…n-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease, has emerged as the most common chronic liver disease in childr…
metabolic syndromeMASHtype 2 diabetesMetabolic dysfunction-associated steatohepatitisT2DMsteatohepatitisChiglitazarvitamin EShanghai Jiaotong University School of Medicinepolyene phosphatidyl choline+1 more
…lic steatohepatitis (NASH), is the hepatic manifestation of the metabolic syndrome. When it co-occurs with type 2 diabetes (T2DM), it presents a s…
type 2 diabetesMetabolic dysfunction-associated steatotic liver diseasesteatohepatitisfibrosis
…are, seems paramount, especially in the high-risk patients with type 2 diabetes and/or obesity. As we discuss in this review, the diagnosis and…
hepatocellular carcinomametabolic dysfunction-associated steatotic liver diseaseMetALDtype 2 diabetes mellitussteatohepatitisalcohol-associated liver diseaseMetabolic dysfunction and alcohol-associated liver diseasefibrosis
…act synergistically to accelerate steatohepatitis, fibrosis and hepatocellular carcinoma. However, the precise mechanisms underlying liver injury in Met…
MASHadvanced liver fibrosissteatohepatitisGDF15
…, and the authors tested the diagnostic performance for at-risk MASH and advanced fibrosis using area under the curve analysis. TSP2…
MASLDMASHautoimmune hepatitisAIHmetabolic dysfunction-associated steatotic liver disease
…bule. It showed that inflammation burden was higher in AIH than MASLD/MASH, despite equivalent portal grades, providing objective sup…
type 2 diabetes mellitussteatohepatitissteatotic liver disease (SLD)metabolic dysfunction-associated steatotic liver disease (MASLD)Cirrhosishepatitisthyroid hormone receptor β agonistsglucagon-like peptide 1 receptor agonistsfibroblast growth factor 21 analogues
…athogenesis. Common environmental risk factors include obesity, type 2 diabetes mellitus, unhealthy diets, sedentary lifestyle and excessive alcohol con…